New drug for hepatitis d tested in kidney patients
NCT ID NCT05760300
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 32 times
Summary
This study looked at how the drug bulevirtide behaves in the body of people with chronic hepatitis D who have normal or reduced kidney function. Researchers measured drug levels in the blood and checked safety over several doses. The goal was to understand how kidneys affect the drug, not to treat the disease directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS D INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Pharma CR, LLC
Miami, Florida, 33147, United States
-
Clinical Pharmacology of Miami, LLC
Miami, Florida, 33014, United States
-
Floridian Clinical Research, LLC
Miami Lakes, Florida, 33016, United States
-
Genesis Clinical Research, LLC
Tampa, Florida, 33603, United States
-
Global Clinical Professionals Research
St. Petersburg, Florida, 33705, United States
-
Massachusetts General Hospital - Renal Associates Clinic
Boston, Massachusetts, 02114, United States
-
Nucleus Network
Saint Paul, Minnesota, 55114, United States
-
Panax Clinical Research
Miami Lakes, Florida, 33014, United States
-
Velocity Clinical Research, New Smyrna Beach
Edgewater, Florida, 32132, United States
Conditions
Explore the condition pages connected to this study.